Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Current Assets (2018 - 2025)

Historic Current Assets for ImmunoTech (AIM) over the last 11 years, with Q3 2025 value amounting to $2.6 million.

  • ImmunoTech's Current Assets fell 6598.41% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 6598.41%. This contributed to the annual value of $4.2 million for FY2024, which is 7131.08% down from last year.
  • As of Q3 2025, ImmunoTech's Current Assets stood at $2.6 million, which was down 6598.41% from $1.0 million recorded in Q2 2025.
  • In the past 5 years, ImmunoTech's Current Assets registered a high of $28.9 million during Q2 2023, and its lowest value of $1.0 million during Q2 2025.
  • Moreover, its 3-year median value for Current Assets was $9.0 million (2024), whereas its average is $10.6 million.
  • Its Current Assets has fluctuated over the past 5 years, first crashed by 6411.03% in 2024, then tumbled by 9010.71% in 2025.
  • Over the past 3 years, ImmunoTech's Current Assets (Quarter) stood at $14.6 million in 2023, then tumbled by 71.31% to $4.2 million in 2024, then crashed by 38.34% to $2.6 million in 2025.
  • Its Current Assets was $2.6 million in Q3 2025, compared to $1.0 million in Q2 2025 and $2.6 million in Q1 2025.